CN101322739B - 一种混合核苷酸、氨基酸与中药保健胶囊的配方及制作工艺 - Google Patents
一种混合核苷酸、氨基酸与中药保健胶囊的配方及制作工艺 Download PDFInfo
- Publication number
- CN101322739B CN101322739B CN200810132907A CN200810132907A CN101322739B CN 101322739 B CN101322739 B CN 101322739B CN 200810132907 A CN200810132907 A CN 200810132907A CN 200810132907 A CN200810132907 A CN 200810132907A CN 101322739 B CN101322739 B CN 101322739B
- Authority
- CN
- China
- Prior art keywords
- nucleotide
- capsule
- chinese medicine
- cortex eucommiae
- radix puerariae
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000002773 nucleotide Substances 0.000 title claims abstract description 47
- 125000003729 nucleotide group Chemical group 0.000 title claims abstract description 47
- 239000002775 capsule Substances 0.000 title claims abstract description 33
- 235000001014 amino acid Nutrition 0.000 title claims abstract description 14
- 150000001413 amino acids Chemical class 0.000 title claims abstract description 14
- 239000003814 drug Substances 0.000 title claims abstract description 14
- 230000036541 health Effects 0.000 title claims abstract description 12
- 238000000034 method Methods 0.000 title description 6
- BVHLGVCQOALMSV-JEDNCBNOSA-N L-lysine hydrochloride Chemical compound Cl.NCCCC[C@H](N)C(O)=O BVHLGVCQOALMSV-JEDNCBNOSA-N 0.000 claims abstract description 14
- 239000000463 material Substances 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 7
- 239000008240 homogeneous mixture Substances 0.000 claims description 3
- 230000001954 sterilising effect Effects 0.000 claims description 3
- 238000004659 sterilization and disinfection Methods 0.000 claims description 3
- 108020004707 nucleic acids Proteins 0.000 abstract description 19
- 102000039446 nucleic acids Human genes 0.000 abstract description 19
- 150000007523 nucleic acids Chemical class 0.000 abstract description 19
- 239000000047 product Substances 0.000 abstract description 10
- 238000006243 chemical reaction Methods 0.000 abstract description 7
- 102000011931 Nucleoproteins Human genes 0.000 abstract description 5
- 108010061100 Nucleoproteins Proteins 0.000 abstract description 5
- 238000010521 absorption reaction Methods 0.000 abstract description 5
- 235000018102 proteins Nutrition 0.000 abstract description 4
- 102000004169 proteins and genes Human genes 0.000 abstract description 4
- 108090000623 proteins and genes Proteins 0.000 abstract description 4
- 238000002156 mixing Methods 0.000 abstract description 3
- 241000208688 Eucommia Species 0.000 abstract 2
- 244000046146 Pueraria lobata Species 0.000 abstract 2
- 235000010575 Pueraria lobata Nutrition 0.000 abstract 2
- 239000013589 supplement Substances 0.000 abstract 1
- 230000037396 body weight Effects 0.000 description 35
- 241000699670 Mus sp. Species 0.000 description 26
- 239000002904 solvent Substances 0.000 description 26
- 239000004615 ingredient Substances 0.000 description 23
- 241000699666 Mus <mouse, genus> Species 0.000 description 19
- 210000000952 spleen Anatomy 0.000 description 14
- 210000004027 cell Anatomy 0.000 description 13
- 239000007788 liquid Substances 0.000 description 13
- 230000000242 pagocytic effect Effects 0.000 description 13
- 238000002474 experimental method Methods 0.000 description 12
- 230000036039 immunity Effects 0.000 description 12
- 210000002540 macrophage Anatomy 0.000 description 12
- 230000006870 function Effects 0.000 description 11
- 239000000243 solution Substances 0.000 description 11
- 230000000694 effects Effects 0.000 description 10
- 210000002966 serum Anatomy 0.000 description 9
- 241001465754 Metazoa Species 0.000 description 8
- 230000002708 enhancing effect Effects 0.000 description 8
- 210000003743 erythrocyte Anatomy 0.000 description 7
- 210000002683 foot Anatomy 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 241000287828 Gallus gallus Species 0.000 description 6
- 108010006464 Hemolysin Proteins Proteins 0.000 description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 239000003228 hemolysin Substances 0.000 description 6
- 238000002347 injection Methods 0.000 description 6
- 239000007924 injection Substances 0.000 description 6
- 210000004698 lymphocyte Anatomy 0.000 description 6
- 210000004988 splenocyte Anatomy 0.000 description 6
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 5
- 239000012153 distilled water Substances 0.000 description 5
- 230000001939 inductive effect Effects 0.000 description 5
- 239000000725 suspension Substances 0.000 description 5
- 230000008961 swelling Effects 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 210000001835 viscera Anatomy 0.000 description 5
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- 206010020751 Hypersensitivity Diseases 0.000 description 4
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 4
- 239000004472 Lysine Substances 0.000 description 4
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 description 4
- 239000012980 RPMI-1640 medium Substances 0.000 description 4
- 208000026935 allergic disease Diseases 0.000 description 4
- 230000007815 allergy Effects 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 229910052799 carbon Inorganic materials 0.000 description 4
- 230000034994 death Effects 0.000 description 4
- 230000003111 delayed effect Effects 0.000 description 4
- 230000003203 everyday effect Effects 0.000 description 4
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 4
- 229960003646 lysine Drugs 0.000 description 4
- 235000018977 lysine Nutrition 0.000 description 4
- 210000003024 peritoneal macrophage Anatomy 0.000 description 4
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- 210000001541 thymus gland Anatomy 0.000 description 4
- 229920000936 Agarose Polymers 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 239000006285 cell suspension Substances 0.000 description 3
- ZQSIJRDFPHDXIC-UHFFFAOYSA-N daidzein Chemical compound C1=CC(O)=CC=C1C1=COC2=CC(O)=CC=C2C1=O ZQSIJRDFPHDXIC-UHFFFAOYSA-N 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 230000036737 immune function Effects 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 230000004089 microcirculation Effects 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 208000006313 Delayed Hypersensitivity Diseases 0.000 description 2
- 108091028664 Ribonucleotide Proteins 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 241000053227 Themus Species 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 229960000583 acetic acid Drugs 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 244000309466 calf Species 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 235000020776 essential amino acid Nutrition 0.000 description 2
- 239000003797 essential amino acid Substances 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 239000012362 glacial acetic acid Substances 0.000 description 2
- 229960000890 hydrocortisone Drugs 0.000 description 2
- VKOBVWXKNCXXDE-UHFFFAOYSA-N icosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCC(O)=O VKOBVWXKNCXXDE-UHFFFAOYSA-N 0.000 description 2
- 210000002490 intestinal epithelial cell Anatomy 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 210000000865 mononuclear phagocyte system Anatomy 0.000 description 2
- 210000004165 myocardium Anatomy 0.000 description 2
- 210000000822 natural killer cell Anatomy 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 239000002336 ribonucleotide Substances 0.000 description 2
- 125000002652 ribonucleotide group Chemical group 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 238000010254 subcutaneous injection Methods 0.000 description 2
- 239000007929 subcutaneous injection Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 230000007306 turnover Effects 0.000 description 2
- 208000030507 AIDS Diseases 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 206010006895 Cachexia Diseases 0.000 description 1
- 206010010144 Completed suicide Diseases 0.000 description 1
- GMTUGPYJRUMVTC-UHFFFAOYSA-N Daidzin Natural products OC(COc1ccc2C(=O)C(=COc2c1)c3ccc(O)cc3)C(O)C(O)C(O)C=O GMTUGPYJRUMVTC-UHFFFAOYSA-N 0.000 description 1
- KYQZWONCHDNPDP-UHFFFAOYSA-N Daidzoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 KYQZWONCHDNPDP-UHFFFAOYSA-N 0.000 description 1
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 1
- VYZAHLCBVHPDDF-UHFFFAOYSA-N Dinitrochlorobenzene Chemical compound [O-][N+](=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 VYZAHLCBVHPDDF-UHFFFAOYSA-N 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 102000000588 Interleukin-2 Human genes 0.000 description 1
- 108010002350 Interleukin-2 Proteins 0.000 description 1
- 102000010789 Interleukin-2 Receptors Human genes 0.000 description 1
- 108010038453 Interleukin-2 Receptors Proteins 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 101000981253 Mus musculus GPI-linked NAD(P)(+)-arginine ADP-ribosyltransferase 1 Proteins 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 206010057249 Phagocytosis Diseases 0.000 description 1
- 229930186706 Puerarin-xyloside Natural products 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 206010061373 Sudden Hearing Loss Diseases 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000036436 anti-hiv Effects 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000007177 brain activity Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 230000001680 brushing effect Effects 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 230000008822 capillary blood flow Effects 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 210000003792 cranial nerve Anatomy 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 239000012531 culture fluid Substances 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 235000007240 daidzein Nutrition 0.000 description 1
- KYQZWONCHDNPDP-QNDFHXLGSA-N daidzein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 KYQZWONCHDNPDP-QNDFHXLGSA-N 0.000 description 1
- 125000000309 desoxyribosyl group Chemical class C1(C[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 208000026500 emaciation Diseases 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- 238000009313 farming Methods 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 229930013032 isoflavonoid Natural products 0.000 description 1
- 150000003817 isoflavonoid derivatives Chemical class 0.000 description 1
- 235000012891 isoflavonoids Nutrition 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- GKQWYZBANWAFMQ-UHFFFAOYSA-M lithium;2-hydroxypropanoate Chemical compound [Li+].CC(O)C([O-])=O GKQWYZBANWAFMQ-UHFFFAOYSA-M 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 239000002366 mineral element Substances 0.000 description 1
- 210000002864 mononuclear phagocyte Anatomy 0.000 description 1
- 239000002777 nucleoside Substances 0.000 description 1
- 150000003833 nucleoside derivatives Chemical class 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000036284 oxygen consumption Effects 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000003836 peripheral circulation Effects 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- 210000004332 phalangeal cell Anatomy 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 208000022530 polyphagia Diseases 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000004853 protein function Effects 0.000 description 1
- 230000017854 proteolysis Effects 0.000 description 1
- NAAXIGQVODQJOV-PXYOAQHISA-N puerarin xyloside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C(C1=C(C(C(C=2C=CC(O)=CC=2)=CO1)=O)C=C1)=C1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)CO1 NAAXIGQVODQJOV-PXYOAQHISA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 229920002477 rna polymer Polymers 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 235000017550 sodium carbonate Nutrition 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 210000003371 toe Anatomy 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
组别(g/kg体重) | 动物数(只) | 足跖肿胀度(mm) | *p值 | *p值 |
溶剂对照组 | 12 | 0.21±0.063 | ||
中剂量配料 | 12 | 0.25±0.049 | >0.05 | |
0.1 | 12 | 0.30±0.054 | <0.01 | >0.05 |
0.2 | 12 | 0.35±0.043 | <0.01 | <0.01 |
0.6 | 12 | 0.33±0.042 | <0.01 | <0.01 |
组别(g/kg体重) | 动物数(只) | 足跖肿胀度(mm) | *p值 | *p值 |
溶剂对照组 | 12 | 0.15±0.043 | ||
中剂量配料 | 12 | 0.15±0.067 | >0.05 | |
0.1 | 12 | 0.19±0.095 | >0.05 | >0.05 |
0.2 | 12 | 0.18±0.066 | >0.05 | >0.05 |
0.6 | 12 | 0.19±0.084 | >0.05 | >0.05 |
组别(g/kg体重) | 动物数(只) | 吞噬指数(a) | *p值 | *p值 |
溶剂对照组 | 12 | 4.77±0.744 | ||
中剂量配料 | 12 | 5.19±0.788 | >0.05 | |
0.1 | 12 | 5.01±0.636 | >0.05 | >0.05 |
0.2 | 12 | 5.30±0.625 | >0.05 | >0.05 |
0.6 | 12 | 5.30±0.710 | >0.05 | >0.05 |
组别(g/kg体重) | 动物数(只) | NK细胞活性(%) | *p值 | *p值 |
溶剂对照组 | 12 | 47.9±18.9 | ||
中剂量配料 | 12 | 48.1±15.8 | >0.05 | |
0.1 | 12 | 59.4±20.4 | >0.05 | >0.05 |
0.2 | 12 | 65.7±17.5 | >0.05 | >0.05 |
0.6 | 12 | 64.2±19.0 | >0.05 | >0.05 |
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200810132907A CN101322739B (zh) | 2008-07-01 | 2008-07-01 | 一种混合核苷酸、氨基酸与中药保健胶囊的配方及制作工艺 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200810132907A CN101322739B (zh) | 2008-07-01 | 2008-07-01 | 一种混合核苷酸、氨基酸与中药保健胶囊的配方及制作工艺 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101322739A CN101322739A (zh) | 2008-12-17 |
CN101322739B true CN101322739B (zh) | 2012-09-19 |
Family
ID=40186540
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200810132907A Active CN101322739B (zh) | 2008-07-01 | 2008-07-01 | 一种混合核苷酸、氨基酸与中药保健胶囊的配方及制作工艺 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101322739B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104605287A (zh) * | 2015-02-15 | 2015-05-13 | 陕西思尔生物科技有限公司 | 一种含支链氨基酸的黑果腺肋花楸食品 |
CN107568740A (zh) * | 2017-09-07 | 2018-01-12 | 哈尔滨医科大学 | 一种保健食品组合物、其制备方法以及在增强免疫力方面的用途 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101116522A (zh) * | 2007-07-26 | 2008-02-06 | 马庆发 | 核酸开胃饮料 |
-
2008
- 2008-07-01 CN CN200810132907A patent/CN101322739B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101116522A (zh) * | 2007-07-26 | 2008-02-06 | 马庆发 | 核酸开胃饮料 |
Also Published As
Publication number | Publication date |
---|---|
CN101322739A (zh) | 2008-12-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101940313B (zh) | 一种增强人体免疫力的保健食品及其制备方法 | |
CN1301666C (zh) | 一种能增强免疫力的保健食品及其制备方法 | |
CN101485463A (zh) | 一种具有多种保健功效的天然产品组方 | |
CN103800390A (zh) | 具有增强免疫力及保肝功能的保健品及其制备方法与应用 | |
CN105412911A (zh) | 一种牡蛎肽饮品 | |
CN100420448C (zh) | 一种增强免疫力的保健食品及其制备工艺 | |
CN100360178C (zh) | 一种抗衰老的药物 | |
CN107441078A (zh) | 一种治疗糖尿病的药物组合物及其制备方法和用途 | |
CN101856112A (zh) | 一种增强人体免疫力的保健食品及其制备方法 | |
CN102524799A (zh) | 一种提高机体免疫力的蛋白粉及其制备方法 | |
CN102526477A (zh) | 一种增强免疫力的药物组合物及其制备方法和应用 | |
CN101810657B (zh) | 含有西洋参的组合物和西洋参茶饮料 | |
CN104667197A (zh) | 一种增强免疫力的组合物及其制备方法和应用 | |
CN105055855B (zh) | 具有改善睡眠、增强免疫力作用的中药组合物及其制备方法和应用 | |
CN101322739B (zh) | 一种混合核苷酸、氨基酸与中药保健胶囊的配方及制作工艺 | |
CN103735621B (zh) | 一种具有降血脂和增强免疫力作用的中药组合物 | |
CN100544739C (zh) | 一种增强免疫功能的药物或保健品及其制备方法 | |
CN104585778A (zh) | 一种提高机体免疫力的蛋白粉及其制备方法 | |
CN102920847B (zh) | 用于增强免疫力的组合物及其制备方法与应用 | |
CN1188406C (zh) | 蒲黄提取物及其制备方法和用途 | |
CN1252241C (zh) | 一种增强免疫力的保健酒及其制备方法 | |
CN104208348A (zh) | 一种具有调节免疫功能的中药制剂 | |
CN102406172B (zh) | 增强免疫力的保健食品及其制备方法 | |
CN102028932A (zh) | 乳清蛋白肽在制备增强免疫力药物、保健食品中的用途 | |
CN106138289A (zh) | 用于增强免疫力改善睡眠的保健口服液及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent for invention or patent application | ||
CB02 | Change of applicant information |
Address after: 266000, 502, 85, Nanning Road, Sifang District, Shandong, Qingdao Applicant after: Li Guangwei Address before: 266000, 502, 85, Nanning Road, Sifang District, Shandong, Qingdao Applicant before: Li Guangwei |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20161118 Address after: The streets of Jiang Jia Tu Zhai she Qu Wang Ge Zhuang Laoshan District 266105 Shandong city of Qingdao Province Patentee after: QINGDAO SHANGYI PHARMACEUTICAL CO., LTD. Address before: 266000, 502, 85, Nanning Road, Sifang District, Shandong, Qingdao Patentee before: Li Guangwei |